RWIBX
Price
$62.66
Change
-$1.77 (-2.75%)
Updated
Dec 18 closing price
TROCX
Price
$26.27
Change
-$0.68 (-2.52%)
Updated
Dec 18 closing price
Ad is loading...

RWIBX vs TROCX

Header iconRWIBX vs TROCX Comparison
Open Charts RWIBX vs TROCXBanner chart's image
American Funds Capital World Gr&Inc R2
Price$62.66
Change-$1.77 (-2.75%)
VolumeN/A
CapitalizationN/A
Touchstone Non-US ESG Equity I
Price$26.27
Change-$0.68 (-2.52%)
VolumeN/A
CapitalizationN/A
RWIBX vs TROCX Comparison Chart
Loading...
View a ticker or compare two or three
VS
RWIBX vs. TROCX commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RWIBX is a Buy and TROCX is a Hold.

FUNDAMENTALS
Fundamentals
RWIBX has more cash in the bank: 121B vs. TROCX (674M). TROCX pays higher dividends than RWIBX: TROCX (1.57) vs RWIBX (1.05). RWIBX was incepted earlier than TROCX: RWIBX (23 years) vs TROCX (10 years). TROCX is a more actively managed with annual turnover of: 110.00 vs. RWIBX (27.00). RWIBX has a lower initial minimum investment than TROCX: RWIBX (250) vs TROCX (500000). TROCX annual gain was more profitable for investors over the last year : 9.10 vs. RWIBX (7.56). RWIBX return over 5 years is better than : 25.73 vs. TROCX (20.44).
RWIBXTROCXRWIBX / TROCX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence23 years10 years-
Gain YTD6.7657.48890%
Front LoadN/AN/A-
Min. Initial Investment2505000000%
Min. Initial Investment IRAN/AN/A-
Net Assets121B674M17,953%
Annual Yield % from dividends1.051.5767%
Returns for 1 year7.569.1083%
Returns for 3 years5.445.7794%
Returns for 5 years25.7320.44126%
Returns for 10 years40.26N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LITM0.180.03
+17.46%
Snow Lake Resources Ltd
ENTG109.362.65
+2.48%
Entegris
ARQ7.01-0.04
-0.57%
Arq
PTCT47.02-1.59
-3.27%
PTC Therapeutics
NUVB2.61-0.20
-7.12%
Nuvation Bio